Polyram in 2025: The Footprint Expanded, but Margins Still Have to Earn It
Polyram kept volumes relatively stable in 2025, opened the Thailand plant, acquired Lapo, and decided to switch to dollar reporting. But profitability weakened, tangible equity fell, and the balance sheet already funded moves that barely showed up in the income statement.
Introduction to the Company
At first glance, Polyram can still be read as a veteran Israeli plastics manufacturer. By 2025 that is no longer enough. In economic terms, this is already a global compounding platform with three product families, 503 employees, more than 1,100 customers, and a manufacturing footprint that spans Israel, the US, the UK, Germany, China, Thailand, Italy, and Morocco. On a first screen, what is working now is still the broad customer base, the geographic footprint, and the company's ability to hold volume. What is weighing on the story is that margins weakened before the new investments had time to prove themselves.
That is also the easy mistake in a superficial read of 2025. Revenue fell 7.6% to NIS 925.6 million, and net profit was cut 46% to NIS 49.5 million. It is tempting to read that as a weak-demand story. That is only part of the story. The company itself says sales volume actually increased 1.6%, or 0.2% excluding Lapo. In other words, 2025 was less about volume collapse and more about selling-price pressure, FX, and weaker profitability in part of the portfolio.
The more important point is that Polyram changed the structure of the business faster than it changed the income statement. The Thailand plant only started producing in October, Lapo was only consolidated from mid-November, and the move to dollar reporting only takes effect from January 1, 2026. That means the balance sheet is already carrying the price of the expansion, while the 2025 P&L still does not show a full operating year of the new platform.
That is the active bottleneck in the story. Polyram is not stuck on whether it has customers. It is stuck on whether it can fill and price the broader platform without paying for that through more inventory, more credit, more overhead, and more margin erosion. That matters even more because the company explicitly says it has no backlog and does not treat unsupplied firm orders as an effective management tool.
At the market level, this does not look like a technical stress story. Market value currently sits around NIS 900 million, while short interest is negligible at 0.05% of float with a 0.48 SIR. So the market is not leaning against Polyram as a survival case. The market is asking whether 2026 becomes a proof year in which the wider footprint starts converting into margins and cash, or another bridge year in which the balance sheet keeps carrying the transition.
Polyram's Economic Map Today
| Layer | 2025 | Why it matters |
|---|---|---|
| Engineering thermoplastic compounds | 56.8% of revenue and 66.0% of operating profit | This is still the core earnings engine of the group |
| Bondyram | 32.7% of revenue and 27.7% of operating profit | This is where the Thailand expansion sits, and where part of the 2026 test lives |
| Polytron | 10.4% of revenue and 6.3% of operating profit | Smaller, but more exposed to automotive and margin pressure |
| Geography | US 26.5% of revenue, Israel 18.0%, Germany 13.1%, rest of Europe 31.1%, Asia 6.4% | The footprint is broad, but so is FX and supply-chain exposure |
| Commercial model | No customer above 10% of revenue, no backlog, inventory is built partly on customer forecasts | The company buys speed and service through the balance sheet, not through long-term contracted revenue |
This chart captures the core of the year. Sales did not implode, but the path from revenue to profit became meaningfully thinner.
Events and Triggers
Lapo changed the profile faster than it changed the annual result
Lapo: On November 18, 2025, Polyram acquired 51% of Lapo Compound in Italy through its UK subsidiary for EUR 12.75 million. The deal also brought in activity in Morocco, contingent consideration of up to EUR 2 million tied to cumulative EBITDA in 2026 through 2030, and a Call and Put on the remaining shares in 2031. This is a material move, not just a small geographic add-on.
But the gap between the balance sheet and the P&L matters here. In 2025, only NIS 10.9 million of revenue and about NIS 2.0 million of comprehensive profit from Lapo were included in the consolidated results, simply because consolidation only began near year-end. On the other hand, the deal already created a NIS 45.1 million net cash outflow, contingent consideration, a Call derivative, and most importantly a Put premium of about EUR 19.9 million that reduced equity. So 2025 already carried the cost of the deal while barely enjoying a full operating contribution from it.
That is exactly why 2026 has to be read differently. If the business combination had taken place at the start of 2025, revenue would have been about NIS 77.1 million. This means the coming year is the first real test of whether Lapo is just a broader map, or also a source of margin, products, and customers.
Thailand is a proof-of-execution story, not just a growth story
Thailand: The subsidiary was established in January 2025, the lease for a roughly 6,500 square meter building near Bangkok was signed in the same month, and production began in October with two Bondyram lines. The plant cost around USD 6 million to build. The company says an additional line is expected to be installed in Thailand during 2026.
The business logic is easy to understand: shorter supply chains into Asia, tariff savings, and a stronger presence in a region where Polyram has already signed distribution agreements in new markets. But the cost side matters too. In 2025 the expansion already showed up through higher operating expenses and higher investment in fixed assets and other items, while still lacking a full year to prove its earnings contribution.
The US is not just a market, it is also part of the protection layer
US: About 26% of the company's revenue comes from the US, but around 83% of that revenue is generated by products manufactured in the US through the local subsidiary. That detail matters because it softens part of the first-order fear around US tariff policy. For Polyram, this is less about a direct tariff hit on most of its US activity and more about demand, availability of goods, and changes in global trade conditions.
At the same time, the company already approved in March 2025 an additional engineering-compounds line in the US plant at an expected cost of USD 1.5 million, with start-up planned during 2026. So the US is not only a sales market. It is also an industrial expansion axis.
Dollar reporting will change how the numbers are read
Dollar reporting: On March 15, 2026, the board decided to change both the functional currency and the presentation currency from NIS to US dollars, effective January 1, 2026. The stated rationale is a more dollarized revenue base, materially dollar-linked operating costs, broader manufacturing activity outside Israel, and a larger share of external dollar funding.
This matters even if it does not change one shekel of 2025 economics. On the one hand, it may reduce some reporting noise from FX. On the other hand, it will make 2025 to 2026 comparisons harder if readers do not separate optics from economics.
This chart matters because it shows that Polyram is not entering 2026 from a fully constrained system. Utilization is still only mid-range, which means the next step depends on filling and pricing the network, not only on adding more steel.
Efficiency, Profitability, and Competition
The central insight here is that the pain in 2025 was not evenly distributed across the company. This was not a case of every engine weakening by the same amount. Engineering compounds remained the relatively strong anchor, while the sharper squeeze showed up in Bondyram and Polytron.
At the group level, revenue fell to NIS 925.6 million while sold volume increased as noted above. Gross profit dropped 15.8% to NIS 180.3 million, and gross margin fell to 19.5% from 21.4%. That makes the core issue clear: 2025 was less about volume and more about price quality versus cost, especially against lower raw-material prices and a stronger shekel.
The fourth quarter makes the point even more clearly. Volume rose 4.9%, yet NIS sales fell 9%, and gross margin dropped to 17.0% from 20.1%. The company's own explanation is straightforward: the shekel strengthened sharply versus the dollar in the fourth quarter, and by roughly 12% over the final eight months of the year. That is a good reminder that margin is still highly exposed to FX even when demand itself is holding up.
Where margin really broke
These charts tell an important story. In engineering compounds, revenue fell 6.2%, but gross profit only declined 2.6% to NIS 116.0 million. That suggests this remains the strongest part of the platform. Even so, operating profit still fell 21.6% to NIS 60.9 million, mainly because of a broader sales setup. In that segment, the pressure came more from the expense layer than from a collapse in gross economics.
Bondyram is where the picture becomes much harder. Revenue fell 10.3% to NIS 303.1 million, but gross profit was down 34.0% and operating profit 40.7%. The company explicitly points to higher operating expenses, mainly because of the expansion in Thailand. In other words, Bondyram is currently both a strategic growth leg and a margin drag until the new footprint matures.
Polytron was weaker as well. Revenue fell 6.2% to NIS 96.6 million, gross profit fell 26.1%, and operating profit declined 25.1%. This is a smaller segment, but one that is more sensitive to automotive conditions and pricing pressure. So even if it is only about a tenth of group sales, it still shapes the market's read of mix quality.
Polyram does not compete on price alone
Polyram operates in a market with many international players, and there is no tariff on imported engineering compounds into Israel. It is easy to jump from that to the conclusion that this is basically a commodity business where price is the whole story. That is too simplistic. The company itself points to technology, fast customer adaptation, broad geography, close raw-material supplier relationships, and direct customer access as critical success factors.
But there is also a yellow flag here that is easy to miss. Polyram has no long-term customer contracts, no backlog, and explicitly states that it does not use unsupplied orders as an effective management tool. That means its commercial edge is built partly on availability, inventory, and service, not on firmly locked future revenue. That works well when demand flows and margins hold. It becomes less comfortable when the company is adding capacity and inventory before profitability has already recovered.
The fact that no customer accounts for more than 10% of revenue is clearly positive. The fact that the company serves more than 1,100 customers also spreads risk. But that does not change the more important economic point: part of Polyram's service advantage is funded through the balance sheet. This is no longer just a sales story. It is a growth-quality story.
Cash Flow, Debt, and Capital Structure
The right cash picture here is the all-in view
This is where an analytical trap matters. If you only look at cash flow from operations, 2025 even looks stronger. Operating cash flow rose to NIS 100.5 million from NIS 40.3 million in 2024, with the company attributing the improvement mainly to lower working capital tied up in customers and inventory. But that is only half the story.
In an all-in cash flexibility view, meaning how much cash is left after the period's real cash uses, the picture is much less generous. Investing activity used NIS 106.0 million in 2025, financing activity used another NIS 1.4 million, and translation differences took away NIS 7.1 million. The end result was a NIS 14.0 million decline in cash, to just NIS 38.3 million.
The message of this chart is simple. Even in a year when operating cash improved, Polyram did not come out with a wider cash cushion. It came out with a bigger business and a heavier balance sheet.
2025 funded a transition, not just normal operations
Within the NIS 106.0 million of investing outflow, the company explicitly points to NIS 45.1 million net invested in the Lapo acquisition and about NIS 25 million of higher investment in fixed assets and other items, mainly because of the Thailand plant. That means a large part of 2025 cash was used to build what management wants 2026 and 2027 to become, not merely to maintain the existing business.
That matters for capital allocation too. During 2025 the company still paid NIS 30 million of dividends, while also funding an acquisition, a new plant, and new lines. This is not an automatic criticism. It is simply a reminder that the company chose to keep distributing and keep expanding at the same time, which leaves less room for error.
Debt is not under stress, but it is doing more work
On covenants, Polyram does not look close to the wall. Net debt to EBITDA stood at 2.34 at year-end versus a maximum of 4. Tangible equity stood at NIS 279 million versus a minimum of NIS 50 million. The company also states that it is in compliance with its bank obligations, and that its foreign subsidiaries are in compliance as well.
But structure matters too. The liabilities-by-maturity schedule totals NIS 314.5 million, of which NIS 273.5 million falls into the first year. That is a fairly short debt stack. Against that, the company has loan facilities of up to NIS 440 million in Israel, of which about NIS 309 million were utilized at year-end, plus available facilities abroad of up to NIS 21 million. So this is not a covenant-stress story, but it is a company whose practical flexibility depends more on rolling working bank lines.
There is also built-in rate sensitivity. The company says about 86% of its funding sources carry variable rates linked to prime, SOFR, or ESTR, and that a 1% increase in interest rates would raise annual finance expense by about NIS 2.7 million. In a year with NIS 49.5 million of net profit, that is no longer a trivial line.
Equity weakened less because of pure earnings and more because of the transaction layer
One more point that should not be missed is what happened to equity. Equity attributable to shareholders fell to NIS 579.1 million from NIS 646.3 million, and tangible equity fell to NIS 279 million from NIS 365 million. Part of that obviously comes from weaker total profit and continued dividends. But the eye-catching move is Lapo: the Put on the remaining 49% was valued at about EUR 19.9 million and reduced equity, before the company even enjoyed a full year of operating contribution.
That is the heart of the distinction between value created and value already accessible to shareholders. Polyram built a broader platform in 2025. But it also loaded itself with more intangibles, goodwill, derivatives, and future obligations that only become worthwhile for shareholders if profitability recovers and stabilizes.
Outlook and Forward View
Before getting into 2026, four non-obvious findings should frame the read:
- The 2025 revenue decline was first and foremost a price and FX story, not a volume-collapse story.
- Lapo changed the balance sheet much more than it changed the 2025 income statement.
- The expanded manufacturing footprint already exists, but there is no backlog behind it.
- Engineering compounds still anchor the group, so the core 2026 question is whether the rest of the system stops diluting that strength.
The right name for 2026 is a proof year and a bridge year at the same time. It is a proof year because the coming year is the first period in which Thailand and Lapo should be visible over a fuller run-rate, and because an additional US line is supposed to come on stream. It is also a bridge year because the balance sheet has already paid for the expansion, and the company now has to show that it can convert that into better margins and cash.
The key question for 2026 is not whether Polyram can keep expanding geographically. It has already shown that it can. The real question is whether it can return to better earnings quality without building overhead and working-capital intensity faster than revenue. Put differently, the next year will not be judged only on sales. It will be judged on whether Bondyram and Polytron recover, and whether Lapo starts showing up as more than balance-sheet complexity.
There are three clear checkpoints over the next two to four quarters. First: cleaner profitability contribution from Thailand and Lapo, not just more cost and complexity. Second: inventory and credit discipline in a company that operates without backlog. Third: the ability to keep funding investment and dividends without leaning still harder on short debt.
It is also worth watching how the market reads the year. The move to dollar reporting may produce a cleaner accounting picture, but it will not replace the real test: whether margins improve, whether the acquisition is integrated, and whether the added capacity gets filled. If the market only sees the currency change or only sees top-line growth, it may miss the actual issue.
The good news is that Polyram does have real room to operate. It has no dependence on a single customer, no immediate covenant pressure, relative tariff protection in the US through local manufacturing, and a core segment that remains very profitable. The less comfortable point is that the company chose a growth model that now needs relatively quick operating proof, because the cost of expansion is already sitting on the system.
Risks
Inventory replaces backlog: This is a material and somewhat non-intuitive risk. Polyram holds inventory to deliver fast, produces some products without specific orders, and explicitly states that it has no backlog. That is a legitimate commercial strategy, but also one that can pressure the balance sheet if demand weakens or price moves against the company.
FX and raw materials: The company itself states that moves in the dollar and euro against the shekel, as well as in the dollar-euro relationship, can materially affect profitability. 2025 already showed that clearly. So even if dollar reporting reduces some presentation noise, it does not change the underlying economics.
Lapo is still in the middle of integration: Lapo carries real commercial potential, but at year-end its customers still did not have credit insurance in place under the group's policy, unlike the established Israeli activity. In addition, the acquisition includes a Put, a Call, and contingent consideration. So this is not just an acquisition of revenue, but also an acquisition of a future obligation layer.
Automotive exposure remains a sensitivity point: Polytron and parts of Lapo are clearly exposed to automotive. Any slowdown in vehicle production or change in ordering conditions could hit exactly the segments where margin already weakened in 2025.
Debt structure is still relatively short: Despite wide covenant headroom, most obligations sit in the first year and depend on ongoing credit facilities. This is not a crisis, but it does make liquidity quality and bank access part of the thesis.
Capital allocation could look too aggressive in hindsight: Dividends, an acquisition, a new plant, and more lines can be the right combination, but only if profitability and cash come back quickly enough. If not, 2025 will look like a year in which the company moved faster on investment than on proof.
Conclusions
Polyram ends 2025 as a broader and more international company, but also as a more complex one. Volumes held up, engineering compounds remained a strong anchor, and the global footprint does create a real service and proximity advantage. On the other hand, Bondyram and Polytron carried most of the margin pressure, Lapo hit the balance sheet faster than it hit earnings, and the full cash picture shows that the company already funded the transition.
Current thesis: Polyram has already built the 2026 platform, but it still has to prove that the platform can earn back margin, cash flow, and shareholder value at the same pace that it expanded.
What changed versus the easier read of earlier years is that Polyram is no longer simply a growth story with solid profitability. From 2025 onward, it has to be read as a company trying to convert a wider industrial footprint into better economics while the balance sheet is already carrying the transition cost.
The strongest counter-thesis: This caution may be too harsh. After all, Polyram enters 2026 with a broad customer base, a profitable core segment, wide covenant headroom, local US production that softens part of the tariff risk, and a global platform that could restore growth and profitability if FX and raw-material conditions stabilize.
What could change the market reading in the short to medium term? First, the early quarters that show a fuller contribution from Thailand and Lapo. Then, the margin quality of Bondyram and Polytron. And finally, the company's ability to keep investing and distributing without leaning harder on the balance sheet.
One sentence on why this matters: for a global industrial company without backlog, real value is not defined by how many plants were added to the map, but by how quickly those plants come back as operating profit, cash, and accessible shareholder equity.
| Metric | Score | Explanation |
|---|---|---|
| Overall moat strength | 3.5 / 5 | Application know-how, a wide customer base, and global reach are real advantages, but not ones that are immune to FX and margin pressure |
| Overall risk level | 3.5 / 5 | There is no immediate covenant stress, but there is still margin pressure, relatively short debt, a no-backlog model, and an acquisition that is not yet proven |
| Value-chain resilience | Medium-high | Multi-region manufacturing supports continuity, but raw materials, logistics, and FX still matter materially |
| Strategic clarity | Medium-high | The direction is clear: deepen the global footprint and fill capacity. What remains open is the speed of the margin recovery |
| Short seller stance | 0.05% of float, very low | Short positioning does not signal a strong market-fundamental dislocation; the main debate is operational and financial execution |
For the thesis to strengthen over the next two to four quarters, Polyram needs to show three things at the same time: cleaner operating contribution from Thailand and Lapo, stabilization in Bondyram and Polytron margins, and cash discipline in a company that funds availability through the balance sheet. What would weaken the thesis is another stretch of acceptable sales but weak margins, greater dependence on short debt, or slow Lapo integration that fails to turn into profitability.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.
Polyram ended 2025 with no impairment charge, but a meaningful part of its headroom is methodological as much as operational. The test still passes even under a more conservative Bondyram read, just with far less room than the first headline figure suggests.
Polyram is not currently short of customers. It is short of contractual visibility: capacity and inventory are already in place, but the model still relies more on forecasts, stock, and customer credit than on firm backlog.
Lapo entered Polyram through the balance sheet first, cash, a Put, a Call derivative, and contingent consideration, well before it had time to prove a durable earnings contribution.